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Abstract  
We report a rare case of isolated thrombocytopenia related to anti-Ro/SSA antibodies. The mother was followed for unlabeled familial 
thrombocytopenia. The mother had positive anti-Ro/SSA antibodies. She was asymptomatic without skin lesions or other criteria neither of 
systemic lupus erythematosus nor other connective tissue disease. Pregnancy was uneventful. The postnatal examination was normal. On the first 
day of life, blood cells count showed thrombocytopenia at 40 x 109/L. Within the second day of life, platelet level dropped to 20 x 109/L. The 
management of thrombocytopenia included platelet transfusion and human immunoglobulin infusion. On the fifth day of life, there has been a drop 
in platelet count to 10 x 109/L requiring renewed platelet transfusion and human immunoglobulin infusion. On the 10th of life platelets rate was 
stable around 60 x 109/L. The infant had no evidence of cardiac, dermatologic or hepatobilary involvement initially or throughout follow up. 
 
 
Pan African Medical Journal. 2015; 22:312 doi:10.11604/pamj.2015.22.312.6839 
This article is available online at: http://www.panafrican-med-journal.com/content/article/22/312/full/ 
 
© Imene Dahmane Ayadi et al. The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original 














Pan African Medical Journal – ISSN: 1937- 8688   (www.panafrican-med-journal.com) 
Published in partnership with the African Field Epidemiology Network (AFENET). (www.afenet.net) 
 










Neonatal lupus erythematosus (NLE) is an uncommon autoimmune 
disease (incidence 1/20000 live births) [1], frequently undiagnosed. 
It is a passive autoimmune disease secondary to the transplacental 
transfer of anti-Ro/SSA, anti-La/SSA and less frequently anti-RNP 
antibodies to the foetus. NLE includes clinical and laboratory 
manifestations, whatever the mother is suffering from a systemic 
autoimmune disease or is totally asymptomatic. Mothers are 
frequently asymptomatic when NLE is diagnosed [2]. During 
pregnancy, anti-Ro/SSA antibodies cross the placenta from the 12th 
week of gestation and persist for 6 to 8 months after birth. The 
major manifestations are skin lesions and congenital heart block. 
Minor manifestations include hepatic dysfunction and hematological 
abnormalities [2]. The pathogenesis NLE is still unclear. The 
association of NLE manifestations with maternal autoantibodies, 
which resolve within 6 months after birth with the clearance of the 
maternal antibodies, is a strong indicator of the importance of 
autoantibodies for determining the pathogenesis of NLE [3]. In fact, 
the presence of autoantibodies is not sufficient. Additional risk 
factors are required for disease development. The amount of 
maternal antibodies, the anti-Ro/SSA avidity antibodies, and genetic 
and maternal factors have been implicated.  
  
  
Patient and observation 
 
A term male neonate born to a 39-year-old mother with a history of 
fetal loss, one was with hydropsfetalis. The mother was followed for 
unlabeled familial thrombocytopenia (her mother, her sister and her 
brother were affected). There was no family history of autoimmune 
disease. The investigation of the mother showed positive anti-
Ro/SSA antibodies. The mother was asymptomatic without skin 
lesions or other criteria neither of systemic lupus erythematosus nor 
other connective tissue disease. The two elder children (a 9-year-old 
son and a 7-year-old daughter) were healthy and they had not 
presented thrombocytopenia in the neonatal period. Pregnancy was 
followed in Charles Nicolle Hospital, a tertiary care centre, it was 
uneventful. The mother had moderate thrombocytopenia about 80 x 
109/L. The delivery was vaginally. The adaptation to extra uterine 
life was good. The postnatal examination was normal. On the first 
day of life, blood cells count showed thrombocytopenia at 40 x 
109/L. In this context, autoimmune thrombocytopenia was the first 
etiology evoked, inherited thrombocytopenia was also discussed. 
Test results of the newborn showed high levels of anti-Ro/SSA 
antibodies. As part of the investigation of an early neonatal 
thrombocytopenia, platelet phenotypage showed compatibility 
between the father, the mother and the newborn. Within the second 
day of life, platelet level dropped to 20 x 109/L. The newborn has 
received platelet transfusion, and human immunoglobulin infusion of 
1 g/Kg/day for two consecutive days with rise of platelet count to 43 
x 109/L. The cranial ultrasound, abdominal ultrasound and ocular 
funds concluded to the absence of hemorrhage. The 
electrocardiogram and the echocardiogram were normal. The liver 
function tests noted the absence of hepatic cytolysis and 
cholestasis. On the fifth day of life, there has been a drop in platelet 
count to 10 x 109/L requiring renewed platelet transfusion and 
infusion of human immunoglobulin. The newborn was discharged on 
the 10th day of life, when there has been a stabilization of platelets 
rate around 60 x 109/L. No lupus dermatitis, cardiac or hepatobiliary 
involvements have appeared during follow-up. Platelet count 





We report a rare cause of neonatal thrombocytopenia, due to 
transplacental transfer of maternal anti-Ro/SSA antibodies. The anti-
Ro/SSA antibodies are generally associated with some connective 
tissue disease especially systemic lupus erythematosus and 
Sjogren's syndrome, but also some undifferentiated connective 
tissue diseases. They can also be present in healthy persons. Their 
estimated prevalence in the general population varies between 0 
and 11% [4]. The risk of having a baby with NLE among unselected 
anti-Ro/SSA antibody-positive women is about 1-2% [1]. The major 
clinical findings in NLE are cardiac heart block, coetaneous 
manifestations, hepatobiliary dysfunction, hematologic 
abnormalities, and exceptionally neurological impairment [2]. The 
incidence of noncardiac features of NLE has rarely been studied. 
Few studies have focused on determining the profile of 
hematological disorders caused by anti-Ro/SSA antibodies. Authors 
have reported hematologic disorders in about 10% of infants with 
NLE [3], consisting of neutropenia, thrombocytopenia [5], rare 
cases of aplastic anemia or hemolytic anemia [6,7]. A Japanese 
study, including 193 cases of neonatal lupus, reported hematological 
disorders in 28 cases (14%), 15 cases (7.5%) had presented 
isolated thrombocytopenia [8]. A Chinese study, including 94 cases 
of neonatal lupus, noted 28 cases of thrombocytopenia (30%) [9]. A 
multicenter prospective study (Toronto, Canada and Milano, Italy), 
had determined the clinical features of 128 newborns born from 124 
pregnancies in 112 women with positive anti-Ro/SSA antibodies, it 
found a high incidence of hematologic abnormalities (27%), the 
most frequent anomaly was neutropenia then anemia, 
thrombocytopenia was present in only 4% of cases. They also noted 
that newborns of asymptomatic mothers with positive anti-SSA/Ro 
antibodies represented 12% (4/33) of infant with hematological 
abnormalities [5]. Neonatal thrombocytopenia secondary to the 
transplacental passage of anti-Ro/SSA maternal antibodies is rare. It 
occurs very infrequently as the only manifestation of NLE [10], as it 
was in our observation. In fact, hematological abnormalities are 
often under diagnosed because almost always asymptomatic. It is a 
transient phenomenon; symptoms are reversible and typically 
disappear within 6 months, in parallel with declining antibodies 





In the reported case, thrombocytopenia was the only feature of 
NLE, which is rare. Given the severity of thrombocytopenia and 
family history, inherited thrombocytopenia was raised. 
Thrombocytopenia was corrected in the 4th month of life, 











All authors participated to the diagnosis and the follow up of the 
patient. All authors have read and agreed to the final version of this 
manuscript and have equally contributed to its content and to the 
management of the case.  
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